ScoreWhy is TransMedics Group, Inc. ?
1
Poor Management Efficiency with a low ROE of 5.81%
- The company has been able to generate a Return on Equity (avg) of 5.81% signifying low profitability per unit of shareholders funds
2
Flat results in Mar 26
- INTEREST COVERAGE RATIO(Q) Lowest at 350.92
- RAW MATERIAL COST(Y) Grown by 7.17% (YoY)
- INTEREST(Q) Highest at USD 7.17 MM
3
With ROE of 40.22%, it has a fair valuation with a 7.18 Price to Book Value
- Over the past year, while the stock has generated a return of -36.46%, its profits have risen by 436.6% ; the PEG ratio of the company is 0
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Below par performance in long term as well as near term
- Along with generating -36.46% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to TransMedics Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is TransMedics Group, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
TransMedics Group, Inc.
-36.46%
-0.78
58.45%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
88.21%
EBIT Growth (5y)
43.65%
EBIT to Interest (avg)
-3.78
Debt to EBITDA (avg)
1.84
Net Debt to Equity (avg)
0.76
Sales to Capital Employed (avg)
0.53
Tax Ratio
2.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.06%
ROE (avg)
5.81%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
7.18
EV to EBIT
31.54
EV to EBITDA
25.23
EV to Capital Employed
6.84
EV to Sales
5.66
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
21.70%
ROE (Latest)
40.22%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 220.22 MM
NET PROFIT(HY)
Higher at USD 112.7 MM
ROCE(HY)
Highest at 45.22%
INVENTORY TURNOVER RATIO(HY)
Highest at 5.62 times
CASH AND EQV(HY)
Highest at USD 950.11 MM
NET SALES(Q)
Highest at USD 173.93 MM
-21What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 350.92
RAW MATERIAL COST(Y)
Grown by 7.17% (YoY
INTEREST(Q)
Highest at USD 7.17 MM
OPERATING PROFIT(Q)
Lowest at USD 25.16 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 14.47 %
PRE-TAX PROFIT(Q)
Lowest at USD 8.48 MM
NET PROFIT(Q)
Lowest at USD 7.32 MM
EPS(Q)
Lowest at USD 0.2
Here's what is working for TransMedics Group, Inc.
Operating Cash Flow
Highest at USD 220.22 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Highest at 5.62 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at USD 173.93 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 950.11 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Depreciation
Highest at USD 11.86 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Depreciation
At USD 11.86 MM has Grown at 58.86%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (USD MM)
Here's what is not working for TransMedics Group, Inc.
Pre-Tax Profit
At USD 8.48 MM has Fallen at -68.19%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 7.32 MM has Fallen at -71.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 7.17 MM has Grown at 113.77%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest Coverage Ratio
Lowest at 350.92
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at USD 7.17 MM
in the last five periods and Increased by 113.77% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD 25.16 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 14.47 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD 8.48 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD 7.32 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD 0.2
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Raw Material Cost
Grown by 7.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at USD 0.28 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
